Literature DB >> 15204668

Psychiatric symptoms in methamphetamine users.

Joan E Zweben1, Judith B Cohen, Darrell Christian, Gantt P Galloway, Michelle Salinardi, David Parent, Martin Iguchi.   

Abstract

The Methamphetamine Treatment Project (MTP) offers the opportunity to examine co-occurring psychiatric conditions in a sample of 1016 methamphetamine users participating in a multisite outpatient treatment study between 1999-2001. Participants reported high levels of psychiatric symptoms, particularly depression and attempted suicide, but also anxiety and psychotic symptoms. They also reported high levels of problems controlling anger and violent behavior, with a correspondingly high frequency of assault and weapons charges. Findings continue to support the value of integrated treatment for co-occurring conditions, especially the importance of training counseling staff to handle psychotic symptoms when needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15204668     DOI: 10.1080/10550490490436055

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  138 in total

1.  Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Richard Rawson
Journal:  Eat Disord       Date:  2011 May-Jun       Impact factor: 3.222

2.  Longitudinal relationship between psychological distress and multiple substance use: results from a three-year multisite natural-history study of rural stimulant users.

Authors:  Brenda M Booth; Geoffrey Curran; Xiaotong Han; Patricia Wright; Sarah Frith; Carl Leukefeld; Russel Falck; Robert G Carlson
Journal:  J Stud Alcohol Drugs       Date:  2010-03       Impact factor: 2.582

3.  The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.

Authors:  Kimber L Price; Stacia M DeSantis; Annie N Simpson; Bryan K Tolliver; Aimee L McRae-Clark; Michael E Saladin; Nathaniel L Baker; Mark T Wagner; Kathleen T Brady
Journal:  Am J Addict       Date:  2011-07-18

4.  Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.

Authors:  William W Stoops; J Adam Bennett; Joshua A Lile; Rajkumar J Sevak; Craig R Rush
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-08-28       Impact factor: 5.067

5.  Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.

Authors:  Keith A Hermanstyne; Glenn-Milo Santos; Eric Vittinghoff; Deirdre Santos; Grant Colfax; Phillip Coffin
Journal:  Drug Alcohol Depend       Date:  2014-08-05       Impact factor: 4.492

6.  A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine.

Authors:  Matthew J Mimiaga; Sari L Reisner; David W Pantalone; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2012-10-03       Impact factor: 5.078

7.  Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.

Authors:  Lian-Yu Chen; Eric C Strain; Pierre Kébreau Alexandre; G Caleb Alexander; Ramin Mojtabai; Silvia S Martins
Journal:  Addict Behav       Date:  2014-02-12       Impact factor: 3.913

8.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 9.  A review of treatment options for co-occurring methamphetamine use disorders and depression.

Authors:  Tracy L Hellem; Kelly J Lundberg; Perry F Renshaw
Journal:  J Addict Nurs       Date:  2015 Jan-Mar       Impact factor: 1.476

10.  Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.

Authors:  Diane Warden; Katherine Sanchez; Tracy Greer; Thomas Carmody; Robrina Walker; Adriane Dela Cruz; Marisa Toups; Chad Rethorst; Madhukar H Trivedi
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.